PLIANT THERAPEUTICS, INC. (PLRX) Return On Equity % [USD] 2019 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Pliant Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2024.
  • Pliant Therapeutics, Inc. Return On Equity for the quarter ending March 31, 2024 was -35.1 %, a 10.2% increase year-over-year.
  • Pliant Therapeutics, Inc. annual Return On Equity for 2023 was -31.2 %, a 38.6% increase from 2022.
  • Pliant Therapeutics, Inc. annual Return On Equity for 2022 was -50.8 %, a 21% decline from 2021.
  • Pliant Therapeutics, Inc. annual Return On Equity for 2021 was -41.9 %, a 111% decline from 2020.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -35.1 +3.97 +10.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -31.2 +19.6 +38.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -32.5 +20.1 +38.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -33.1 +25.9 +43.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -39.1 +9.92 +20.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -50.8 -8.81 -21% Oct 1, 2022 Dec 31, 2022
Q3 2022 -52.6 -16.3 -45% Jul 1, 2022 Sep 30, 2022
Q2 2022 -59 -29.2 -98% Apr 1, 2022 Jun 30, 2022
Q1 2022 -49 -23 -88.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -41.9 -22 -111% Oct 1, 2021 Dec 31, 2021
Q3 2021 -36.3 -52.8 -319% Jul 1, 2021 Sep 30, 2021
Q2 2021 -29.8 -188 -119% Apr 1, 2021 Jun 30, 2021
Q1 2021 -25.9 +1.15 +4.25% Jan 1, 2021 Mar 31, 2021
Q4 2020 -19.9 -20.6 -3117% Oct 1, 2020 Dec 31, 2020
Q3 2020 16.6 Jul 1, 2020 Sep 30, 2020
Q2 2020 159 Apr 1, 2020 Jun 30, 2020
Q1 2020 -27.1 Jan 1, 2020 Mar 31, 2020
Q4 2019 0.66 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.